The Michael J. Fox Foundation for Parkinson's Research announced awards totaling approximately $10.1 million for five new clinical studies and 14 pre-clinical therapeutic development projects. The funding includes $2.5 million to drive four new clinical trials under the Clinical Intervention Awards, one of the Foundation's Edmond J. Safra Core Programs for PD Research.
Grantees under the 2010 Clinical Intervention Awards are:
Two separate awardees will independently work on novel formulations of levodopa designed to create an easier treatment regimen for patients while also lessening the complications and symptoms of PD that are believed to be exacerbated by extreme fluctuations in blood levels of levodopa:
For information on the 15 pre-clinical therapeutic development projects receiving awards totaling $2 million, please visit PD Online Research.
In addition to today's announcement, the Foundation recently launched the Parkinson's Progression Markers Initiative, a landmark clinical study seeking biomarkers of Parkinson's disease. The Foundation has committed $8.6 million to PPMI to date.
'/>"/>
Contact: Holly Barkhymer hbarkhymer@michaeljfox.org 212-509-0995 x242 The Michael J. Fox Foundation for Parkinson's Research Source:Eurekalert |